Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Passage Bio, Inc. is a biopharmaceutical company dedicated to pioneering genetic therapies for conditions affecting the central nervous system.

52W Range

7thpctl

Volume

0.25×avg

Market Cap

14.52MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Passage Bio, Inc.

PASGNASDAQ Global Select·USD·Closed

Passage Bio, Inc.

PASGNASDAQ·USD·Closed

$4.52

+4.39%

$4.52

+$0.19 (4.39%)

52W Range

7thpctl

Volume

0.25×avg

Mkt Cap

14.52MUSD

P/E

-0.4TTM

Div Yield

–ann

PASG: Passage Bio, Inc. Stock Analysis | finqOS